1. Home
  2. VCYT vs NVG Comparison

VCYT vs NVG Comparison

Compare VCYT & NVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCYT
  • NVG
  • Stock Information
  • Founded
  • VCYT 2006
  • NVG 1999
  • Country
  • VCYT United States
  • NVG United States
  • Employees
  • VCYT N/A
  • NVG N/A
  • Industry
  • VCYT Medical Specialities
  • NVG Investment Managers
  • Sector
  • VCYT Health Care
  • NVG Finance
  • Exchange
  • VCYT Nasdaq
  • NVG Nasdaq
  • Market Cap
  • VCYT 2.4B
  • NVG 2.5B
  • IPO Year
  • VCYT 2013
  • NVG N/A
  • Fundamental
  • Price
  • VCYT $32.43
  • NVG $11.97
  • Analyst Decision
  • VCYT Buy
  • NVG
  • Analyst Count
  • VCYT 9
  • NVG 0
  • Target Price
  • VCYT $39.89
  • NVG N/A
  • AVG Volume (30 Days)
  • VCYT 1.3M
  • NVG 568.8K
  • Earning Date
  • VCYT 11-05-2025
  • NVG 01-01-0001
  • Dividend Yield
  • VCYT N/A
  • NVG 4.65%
  • EPS Growth
  • VCYT N/A
  • NVG N/A
  • EPS
  • VCYT 0.34
  • NVG N/A
  • Revenue
  • VCYT $479,129,000.00
  • NVG N/A
  • Revenue This Year
  • VCYT $14.19
  • NVG N/A
  • Revenue Next Year
  • VCYT $9.68
  • NVG N/A
  • P/E Ratio
  • VCYT $96.53
  • NVG N/A
  • Revenue Growth
  • VCYT 19.91
  • NVG N/A
  • 52 Week Low
  • VCYT $22.61
  • NVG $9.68
  • 52 Week High
  • VCYT $47.32
  • NVG $12.21
  • Technical
  • Relative Strength Index (RSI)
  • VCYT 68.26
  • NVG 66.37
  • Support Level
  • VCYT $29.38
  • NVG $11.78
  • Resistance Level
  • VCYT $30.69
  • NVG $11.88
  • Average True Range (ATR)
  • VCYT 1.11
  • NVG 0.07
  • MACD
  • VCYT 0.15
  • NVG 0.03
  • Stochastic Oscillator
  • VCYT 93.72
  • NVG 97.78

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

About NVG Nuveen AMT-Free Municipal Credit Income Fund

Nuveen AMT-Free Municipal Credit Income Fund is a diversified, closed-end management investment company. Its objective is to provide current income exempt from regular federal income tax and federal alternative minimum tax applicable to individuals and enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the investment adviser believes are underrated or undervalued or represent undervalued municipal market sectors.

Share on Social Networks: